This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Review

H. SILVETTE, Ph.D.; P. S. LARSON, Ph.D.; H. B. HAAG, M.D.

Arch Intern Med. 1961;107(6):915-931.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Nicotine (which we may here consider to be the active ingredient of that vast chemical complex known as tobacco-smoke) is properly regarded as a neurotropic drug, and it has been as aptly suggested that it be included in that more-recently-named category of "psychopharmacological agents"; yet it is paradoxical that many of the more important "somatic" effects of nicotine (and side-effects of smoking) are mediated through two very sensitive endocrine mechanisms, that of the adrenals and of the post-pituitary gland.⁸² But this is, after all, only a seeming paradox; for the nicotine-induced hormonal secretion of epinephrine and vasopressin, respectively, is in fact neurogenic; and nicotine ordinarily exerts its action on these glands, directly or reflexly, via their very sensitive nervous connections.

To give some illustration of the ubiquity of the pharmacological effects said by various authors—but not without occasional contradiction—to result, either in whole or in part, from nicotine-induced epinephrine . . . [Full Text PDF of this Article]

Author Affiliations
RICHMOND, VA.

From the Department of Pharmacology, Medical College of Virginia.

Footnotes
Submitted for publication July 13, 1960.

Supported by a grant from the Tobacco Industry Research Committee.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?